anthranilamide has been researched along with oxadiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Cao, M; Chen, J; Hong, KH; Ji, M; Li, L; Sun, C; Wei, H; Wu, X; Zong, X | 1 |
| Cai, J; Cao, M; Chen, B; Chen, J; Hong, KH; Ji, M; Li, L; Sun, C; Wang, P; Wei, H; Wu, X; Zhou, G; Zong, X | 1 |
2 other study(ies) available for anthranilamide and oxadiazoles
| Article | Year |
|---|---|
Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Models, Molecular; Molecular Structure; ortho-Aminobenzoates; Oxadiazoles; Repressor Proteins; Structure-Activity Relationship | 2015 |
Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Discovery; Drug Screening Assays, Antitumor; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Ketones; Molecular Docking Simulation; ortho-Aminobenzoates; Oxadiazoles; Protein Binding; Repressor Proteins; Structure-Activity Relationship; Vorinostat | 2015 |